Published: Fri, August 31, 2018
Health Care | By Cedric Leonard

Blood pressure drug recall: FDA warns of potentially 'life-threatening' labeling mixup

Blood pressure drug recall: FDA warns of potentially 'life-threatening' labeling mixup

The individual lot is labeled PW05264.

Accord Healthcare has recalled one lot of 12.5-milligram hydrochlorothiazide tablets because the 100-count bottle was discovered to contain 100 spironolactone tablets.

A pharmaceutical company has issued a voluntary nationwide recall of a popular blood pressure medication, hydrochlorothiazide, after a lot of the company's product was found to be mislabeled, the Food and Drug Administration said this week.

The medication found in the bottle was created to reduce a hormone that affects blood pressure.

But, if one drugs is used instead of the other in particular patients, the results can be life-threatening, according to the FDA.

Potential Tropical Cyclone 6 forms off of the coast of Africa
It was traveling west at 8 miles per hour and had maximum sustained winds of 75 miles per hour . The east coast sea breeze got a quick start before lunch Thursday and moved quickly west.

Hydrochlorothiazide tablets are used to manage hypertension either alone or with other antihypertensive drugs.

"Use of spironolactone tablets instead of hydrochlorothiazide tablets, poses the risk of contracting hyperkalemia (increase potassium levels) in certain individuals, resulting in adverse events that range from limited health consequences to life-threatening situations in certain individuals", the recall notice states.

They are debossed with an "H" on one side and a "1" on the other side. Anybody who experiences adverse reactions should report them to the FDA's MedWatch Adverse Event Reporting program, which can be accessed online, sent by regular mail, or by fax.

While both hydrochlorothiazide and spironolactone can be used to treat high blood pressure, spironolactone causes the body to store potassium and flush out excess water and sodium.

Not all drugs containing valsartan are being recalled, but this week the FDA expanded the list of drugs being recalled. Hydrochlorothiazide treats high blood pressure and fluid retention, says

Like this: